Title: Ron Travaglino
1Ron Travaglino Director
2Accommodating Patients Requests For Medical
Treatment Without Allogeneic Blood
3Bloodless Medicine and Surgery Defined
- Use of New and Existing Techniques, Procedures,
Technology, and Equipment to reduce or eliminate
the need to use allogeneic (donor) blood
4Englewood Hospital Medical Center Bloodless
Institute
- Patients from 40 States in USA
- Patients from 40 Countries
- Major Cardiac, Orthopedic, Vascular,
Neurological, Gynecological, Hepatic, Thoracic,
Urologic Surgery - Hundreds of Transfers from Other Hospitals
including those claiming to be Bloodless
Centers
5Bloodless Medicine and Surgery - A
Multidisciplinary Effort
- Surgeons
- Anesthesia Personnel
- Nurses
- Internists
- Hematologists
- Administrators
- Ancillary Staff
- Pharmacy
- Lab
- Blood Bank
6Englewood Hospital and Medical Center-Bloodless
Institute
- 200 Physicians
- Six dedicated staff members
- Patient Intake and care coordination
- Patient Education, Advance Directives
- Preoperative patient preparation
- Patient Advocacy
- Four Medical Directors
- Regular nursing, physician, staff education
- Regular community education
7Bloodless Medicine and Surgery Why?
- Crisis in Blood Supply and Availability
- Blood Borne Disease Risks
- Patient refusal/reluctance
- Cost Considerations
8Bloodless Medicine and Surgery - Why?
- Patients choice
- Blood is a precious fluid
- Increasing Elderly Population
- By 2030, annual shortfall of 4 million units in
USA - Less than 5 of eligible population donates in
USA - Blood Transfusion is associated with Significant
Cost
9Reasons That Support Bloodless Medicine and
Surgery
- Blood therapy is expensive-proven risks and
hazards - Public health concerns
- Shortage of blood nationally
- Medical devices and pharmaceuticals facilitate
bloodless care - No significant increase of morbidity and
mortality - Overall decrease in healthcare costs
- Enhances practical clinical experience
- Growing patient population supplies data for more
education - Supports patients rights and autonomy
- Good economics
10Who are the Patients?
- Religious Motivation
- Primarily Jehovahs Witnesses
- Non - Religious Motivation
- Concern over blood safety
- Personal/Family Member History of Problematic
Transfusion - Vegetarians
11Jehovahs Witnesses and Associates - World
Population
- 1985 - 7,792,109
- 1995 - 13,147,201
- 2000 - 14,872,086
- 2007 - 16,675,113
12Jehovahs Witnesses
- Do Not Refuse Medical Care
- - only blood transfusions
- Refusal of Blood not a RIGHT TO DIE Issue
- Actively Pursue Non Blood Medical Management
13Jehovahs Witnesses Do Accept
- Various Surgical, Medical, Anesthesia, Nursing
Modalities to Conserve/Preserve Blood - All Other Types of Standard Medical Care
14(No Transcript)
15Fractional Components
- Medical/Scientific
- Line of Reasoning
- Realistic consideration of physical Risks vs.
Benefits
- Conscientious Line of Reasoning
- Thoughtful consideration of other Risks vs.
Benefits - (i.e. spiritual)
16Blood Fractions - Examples
- ALBUMIN (EPO)
- IMMUNE GLOBULINS
- CLOTTING FACTORS (some)
- CRYOPRECIPTATES
- HEMOGLOBIN BASED PRODUCTS
- More and More Available
17Making the Decisions - Medical Line of Reasoning
- Blood Fractions are fundamental tools in hands of
Physicians - Many non blood alternatives fit into these
categories - Some used only in the face of imminent loss of
life, so small risk of disease is tolerable
18Accommodating PatientsLegal and Ethical
Principles
- Bodily Self Determination
- Upheld by US Supreme Court and State Courts
- Right to Refuse Treatment
- Special Considerations for Minors
19Risks of Blood Transfusions
- Incompatibility
- (ABO and other groups)
- Infectious complications
- Immunomodulatory
- Resource availability
- Risk to Benefit Ratio
20Blood Collection and Transfusion - US in 1999
- 13,225,000 allogeneic units collected
- 12,020,000 allogeneic units transfused
- 226,000 lost to screening (1.7)
- 787,000 outdated (5.9)
- 112/1709 (6.6) of hospitals cancelled surgery
because of no blood
21(No Transcript)
22Transfusion Behavior (Survey) 1997
- US physicians 100 MDs all specialists.
- At what Hb. would you be transfused?
- Hb. of 9 gms/dl 0
- Hb. of 7 gms/dl /-5
- Hg. of 5 gms/dl /-14
- Lower? /-19.5
- gt 78 have Tx. Patients with Hb. 9.0 gms
- Role of guidelines in Transfusion Medicine Bifano
et.al.
23Bloodless Institute Risk Management
- No Legal Cases or Consequences attributable to
Bloodless Program - Patients sign Release of Liability Form on
admission - No change in Hospitals Liability Insurance
Coverage
24Hospital Liability?
- The court allowed the plaintiff's negligence
action against the hospital for not having given
recipient notice of the danger of transfusions.
- Estate of Jane Doe v. Vanderbilt University, Inc.
1993
25Bloodless Care and Cost Savings
- Cost of acquiring ONE unit of Packed Red Blood
Cells is approximately 225 US - TRUE cost much higher (transport, storage,
administration, potential complications) - Study found allogeneic transfusions associated
with 1000-1500 US incremental Hospital costs
26Management of Anemia
- Careful Evaluation and Diagnosis
- Accurate History and Physical
- Avoid and/or Manage Preoperatively if at all
Possible - Recombinant Human Erythropoietin (Epoetin Alfa)
27EPO DOSING REGIMEN
- 300-600 Units/Kilogram, from three to ten weeks
before Surgery, Subcutaneously or Intravenously - Postoperative Bleeding
- GI Bleeding
- Oncology
- Postpartum
- GYN Bleeding
28Adjuvants to EPO
- Folic Acid (1 mg/day)
- Vitamin B-12
- Ascorbic Acid (500 mg/day)
- Iron (Oral or Intravenous)
29Bloodless Medicine and Surgery - Intraoperative
Surgical Management
- Meticulous Hemostasis
- Electrocautery
- Laser Surgery
- Argon Beam Coagulation
- Tissue Adhesives
- Cell Salvage
30Bloodless Medicine and Surgery - Anesthesia
Management
- Embolization
- Positioning of patient
- Hypotensive anesthesia
- Induced hypothermia
- ACUTE NORMOVOLEMIC HEMODILUTION
- Aprotinin, DDAVP, Tranexamic acid, conjugated
estrogens
31Iatrogenic Blood Loss
- Average ICU Patient can lose 1000 ml or more of
blood PER WEEK from phlebotomy for laboratory
testing
32Routine Blood Testing
- Routine Blood Tests are often UNECESSARY in
Patients who refuse transfusion, or if no changes
in clinical management will result from
information obtained
33Transfusion ? Immunomodulation
-
- Multiple studies show that transfusion is
associated with increased risk of earlier cancer
recurrence, lack of response to cancer treatment,
and serious postoperative infection.
34(No Transcript)
35SHOT - Serious Hazards Of Transfusions
- 24 month study in UK and Ireland (1996-1998)
- 424 hospitals surveyed
- 39 (164) responded
- Outcome measures
- Death
- wrong blood - wrong patient
- acute and delayed transfusion reactions
- Acute lung injury
- Graft vs. host reaction
- Purpura
- Infections
36SHOT - Serious Hazards Of Transfusions
- 366 major adverse events reported
- 52 were due to wrong blood to patient
- 22 total deaths
- 3 - ABO
- 12 - infections, 4 - bacterial, 7- viral,
1 - malaria
37When does a patient get transfused?
38(No Transcript)
39Risks of blood transfusion( Per unit of blood
U.S.A. )
- Minor allergic reactions 1100
- Viral hepatitis (A,B,C,D,G) 150,000
- Hemolytic reactions 16,000
- Fatal hemolytic reactions 1600,000
- HIV infection 1420,000
- HTLV-I/II 1200,000
- Bacterial infections 12,500
- Acute lung injury 1500,000
- Anaphylactic shock 1500,000
- Graft Vs. host disease Rare
- Immunosuppression 11
40Infectious complications
- Viruses
- HIV-1,2
- HTLV-I,II
- Cytomegalovirus
- Epstein-Barr virus
- Parvovirus B19
- Creutzfeldt-Jakob disease(CJD)
- TTV
- West Nile
- Spirochetes
- Treponema pallidum
- Borrelia burgdorferi
- Parasites
- Plasmodia
- Babesia microlti
- Trypanosoma crizi
- Toxoplasma gondii
- Leishmania donovani
- Bacteria
- Staphylococcus
- Salmonella
- Yersinia enterocolitica
41To all who received blood fromJanuary 1991 to
December 1996 in aNew York/New Jersey hospital
- Here is important information from the New York
Blood Center for anyone who received a
transfusion of red blood cells, platelets, or
plasma in a New York or New Jersey hospital
between January 1991 and December 1996. - During that period, there may have been a problem
with the way New York Blood Center performed
testing of blood for viral infections. As a
result, recipients of donated blood products
during that period may face a potential risk of
transfusion-transmitted infections, such as HIV
and hepatitis.
42Risk versus Benefit
- Known risks include disease transmission,
reactions, immunomodulation - Benefit of blood unproven
- Storage dramatically diminishes bloods
effectiveness as O2 carrier - Known risks outweigh perceived benefits
43What is Acceptable Risk?
- To patient
- To physician
- To society
- Age-based?
- Diagnosis-based?
44Blood Transfusion is Life Saving?
- NO proof except when used as volume replacement
in resuscitation - There are safer, equally effective alternatives
such as saline and colloids - NO trials that demonstrate better survival from
blood transfusion
45NJ Institute of Bloodless Medicine and Surgery
Patient Totals
- Year pt Mortality
- 1994 510 0
- 1995 650 1
- 1996 1,057 1
- 1997 1,267 1
- 1998 1,949 1
- 1999 2,540 1
- 2000 2,751 1
- 2001 3,047 1
46Range of Low Hgb. Survivors
- 5 patients lt2.0 gms
- 16 patients 2.0 - 3.0 gms
- 25 patients 3.0 - 4.0 gms
- 69 patients 4.0 - 5.0 gms
- (4 _at_ 1.7 gms 1 _at_ 1.3 gms!)
- 11/30/07
47Clinical Outcomes
- Our data only
- January 1997 to June 1999
- Colectomy
- Total Hip Arthroplasty
- Total Knee Arthroplasty
- Abdominal Hysterectomy
48Increased Length of Hospital Stay and
CostsTransfused vs. Non Transfused
PatientsSelected Surgical ProceduresEnglewood
Hospital and Medical Center, NJJanuary 1997
June 1999
- Procedure Average LOS Average Cost (US
Dollars) - Colectomy 1.86 8,300.
- Total Hip Arthroscopy 0.43 990.
- Total Knee Arthroscopy 0.43 797.
- Abdominal Hysterectomy 1.19 6,723.
49Resources
- www.bloodlessmed.com
- www.sabm.org
50COMMUNICATIONCOOPERATIONNOT CONFRONTATION
51(No Transcript)
52